Last reviewed · How we verify
B1344
At a glance
| Generic name | B1344 |
|---|---|
| Also known as | pegylated conjugate of recombinant human mutated fibroblast growth factor 21 |
| Sponsor | Tasly Biopharmaceuticals Co., Ltd. |
| Modality | Small molecule |
| Phase | Phase 1 |
Approved indications
Common side effects
Competitive intelligence
For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:
- B1344 CI brief — competitive landscape report
- B1344 updates RSS · CI watch RSS
- Tasly Biopharmaceuticals Co., Ltd. portfolio CI